Oncogenic YAP accelerates S-phase entry by shortening G1, leading to replication stress and sensitivity to CHK1 inhibition.

D Molecular Therapeutics said it is streamlining operations to offset expected expenses as it accelerates the timelines for its Phase III trials.

Researchers successfully developed a nanomaterial capable of simultaneously performing cancer diagnosis, treatment, and ...

Scientists have made a groundbreaking discovery in understanding the BRCA2 gene, offering new hope for cancer patients and those at high risk of developing the disease.

A recent review by Prof. Zhu Bing and Associate Professor Xiong Jun from the Institute of Biophysics of the Chinese Academy ...

Researchers at McMaster University, Cleveland Clinic and Case Comprehensive Cancer Center have uncovered how a protein long ...

A study by Children's Medical Research Institute (CMRI) researchers reveals a new group of proteins that guide the powerful ...

Why did two private equity firms with more than $460 billion under management want a little old gene therapy biotech called ...

Melanin can either protect or worsen hereditary hearing loss depending on genetic context, as reported by researchers from ...

Smoke from wildfires and structural fires doesn t just irritate lungs it actually changes your immune system. Harvard ...

Deleting a gene called PTEN in certain brain cells disrupts the brain’s fear circuitry and triggers anxiety-like behavior in ...